GLP-1 The GLP-1 Pipeline at a Glance: Oral Drugs, New Agonists, and What Comes Next 2026 is the year of oral GLP-1s. Orforglipron is approved. Oral semaglutide is in Phase 3. The injection-only era is ending.
